Related Experiment Video
Updated: May 6, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma
You-Soub Lee1, Jung-Won Lee, Ju-Won Jang
1Department of Biochemistry, College of Medicine, Chungbuk National University, Cheongju 361-763, South Korea.
Abstract:
Targeted inactivation of Runx3 in mouse lung induced mucinous and nonmucinous adenomas and markedly shortened latency of adenocarcinoma formation induced by oncogenic K-Ras. RUNX3 was frequently inactivated in K-RAS mutated human lung adenocarcinomas. A functional genetic screen of a fly mutant library and molecular analysis in cultured cell lines revealed that Runx3 forms a complex with BRD2 in a K-Ras-dependent manner in the early phase of the cell cycle; this complex induces expression of p14(ARF)/p19(Arf) and p21(WAF/CIP). When K-Ras was constitutively activated, the Runx3-BRD2 complex was stably maintained and expression of both p14(ARF) and p21(WAF/CIP) was prolonged. These results provide a missing link between oncogenic K-Ras and the p14(ARF)-p53 pathway, and may explain how cells defend against oncogenic K-Ras.
Insights
Runx3 inactivation promotes lung adenocarcinoma in mice and humans. Runx3-BRD2 complex formation, induced by oncogenic K-Ras, regulates cell cycle genes involved in tumor suppression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Runx3 is a tumor suppressor gene.
- Oncogenic K-Ras is a common driver mutation in lung cancer.
- The precise mechanisms linking K-Ras activation to tumor suppression pathways are not fully understood.
Purpose of the Study:
- To investigate the role of Runx3 in K-Ras-driven lung tumorigenesis.
- To elucidate the molecular mechanisms by which Runx3 and K-Ras interact.
- To identify potential therapeutic targets for lung adenocarcinoma.
Main Methods:
- Targeted inactivation of Runx3 in mouse lung models.
- Analysis of human lung adenocarcinoma samples with K-RAS mutations.
- Functional genetic screening in Drosophila.
- Molecular analysis of cell lines.
Main Results:
- Runx3 inactivation accelerated K-Ras-induced lung adenocarcinoma formation in mice.
- RUNX3 was frequently inactivated in human K-RAS mutated lung adenocarcinomas.
- Runx3 forms a complex with BRD2 in a K-Ras-dependent manner.
- This complex regulates the expression of cell cycle inhibitors p14(ARF) and p21(WAF/CIP).
- Constitutive K-Ras activation led to stable Runx3-BRD2 complex formation and prolonged p14(ARF)/p19(Arf) and p21(WAF/CIP) expression.
Conclusions:
- Runx3 acts as a tumor suppressor in K-Ras-driven lung cancer.
- The Runx3-BRD2 complex is a key mediator linking oncogenic K-Ras to the p14(ARF)-p53 pathway.
- These findings provide insights into cellular defense mechanisms against oncogenic K-Ras and suggest potential therapeutic strategies.
Related Concept Videos
Inheritance of Chromatin Structures
lncRNA - Long Non-coding RNAs
The Ras Gene
Ras is a...
Non-LTR Retrotransposons
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...

